Co-Diagnostics (NASDAQ:CODX) Part of Silicon Slopes Initiative Inking “Big Dollar Contracts” for Coronavirus Testing New York City, April 28, 2020 (GLOBE NEWSWIRE) -- Co-Diagnostics, Inc. (Nasdaq:CODX) (the Company), a Utah biotech with a unique, patented molecular diagnostic testing platform, recently announced...

Co-Diagnostics (NASDAQ:CODX) Prepares Coronavirus Test as World Health Organization Weighs Global Health Emergency New York City, Jan. 23, 2020 (GLOBE NEWSWIRE) -- Shares of Co-Diagnostics, Inc. (Nasdaq:CODX), a biotech company with a patented platform for the development of molecular diagnostic tests, leaped...